The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic (scientific article)

Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains

Q33305656

Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure

Q33371085

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Q34437074

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

Q34450381

Prevalence of monoclonal gammopathy of undetermined significance

Q34506801

International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders

Q34884527

Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry

Q36107692

Dangerous small B-cell clones.

Q36516158

Screening panels for detection of monoclonal gammopathies

Q37172007

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma

Q37528072

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

Q37835574

A practical approach to the diagnosis of systemic amyloidoses.

Q41505050

Detecting monoclonal immunoglobulins in human serum using mass spectrometry

Q49090078

Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue.

Q50526227

Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry.

Q51576432

Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine

Q58030328

Glycosylation of immunoglobulin light chains associated with amyloidosis

Q58300664

P433

issue

P304

page(s)

772-779

P577

publication date

2017-04-25

P1433

published in

American Journal of Hematology

Q4744246

P1476

title

The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic

P478

volume

Reverse relations

cites work (P2860)

Q61799687	A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis
Q89435483	Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patients
Q89882077	Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis
Q98891265	Comparing measures of hematologic response after high-dose melphalan and stem cell transplantation in AL amyloidosis
Q91972629	Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement
Q90440259	Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
Q50224356	Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients.
Q41176998	High sensitivity blood-based M-protein detection in sCR patients with multiple myeloma
Q99583793	How to quantify monoclonal free light chains in plasma cell disorders: which mass spectrometry technology?
Q98891237	Indicators of profound hematologic response in AL amyloidosis: complete response remains the goal of therapy
Q91800428	MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins
Q96771728	N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression
Q47561519	New concepts in the treatment and diagnosis of amyloidosis
Q47104926	Pseudo-monoclonal gammopathy: a report of four cases
Q91739667	Systemic amyloidosis: moving into the spotlight
Q90603509	The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis
Q93074047	WITHDRAWN: [Treatment of AL amyloidosis]